Latest Conference

Silvia Munoz-Price, MD, PhD, Associate Professor of Clinical Medicine at the Institute for Health and Society, Medical College of Wisconsin, and Enterprise Epidemiologist for Froedtert & the Medical College of Wisconsin, discusses some issues that she believes the subspecialty needs to address.

Matt Linam, MD, MS, Assistant Professor, Pediatric Infectious Diseases, University of Arkansas for Medical Sciences, explains a strategy used at his healthcare facility to prevent respiratory viral HAIs in children.

Lauri A. Hicks, DO, Director, Office of Antibiotic Stewardship, Centers for Disease Control and Prevention, discusses what we know about antibiotic prescribing habits among dentists.

Researchers collected biofilms from several hospitals in four non-neighboring countries to determine if the persistence of multidrug-resistant organisms in biofilms on hospital surfaces was a worldwide problem.

David A. Schwartz, MD, MS Hyg, FCAP, clinical professor of pathology at Medical College of Georgia, Augusta University, explains how congenital infection with Zika virus differs from congenital infection with other viruses.

Madeline King, PharmD, assistant professor of Clinical Pharmacy at the University of the Sciences, Philadelphia College of Pharmacy in Philadelphia, Pennsylvania, discusses the significance of the findings of her research on Ceftazidime-Avibactam.

Matt Linam, MD, MS, Assistant Professor, Pediatric Infectious Diseases, University of Arkansas for Medical Sciences, explains how families and visitors can play a role in transmitting healthcare-associated infections.

Emily Heil, PharmD, BCPS-AQ ID, assistant professor at the University of Maryland School of Pharmacy, and Contagion® Editorial Advisory Board Member, discusses how antibiotic allergies can affect stewardship.

David A. Schwartz, MD, MS Hyg, FCAP, clinical professor of pathology at Medical College of Georgia, Augusta University, explains his research, which focuses on mechanisms of transmission of the Zika virus from mother to child.

Lilian Abbo, MD, chief, infection prevention & control and antibiotic stewardship, Jackson Health System, associate professor of clinical medicine, Division of Infectious Diseases, Miller School of Medicine, University of Miami, explains the importance of rapid diagnostic testing.

Alice Panchaud, PharmD, PhD, clinical pharmacist and pharmacoepidemiologist, CHUV, Lausanne University Hospital, Switzerland, explains how researchers can anonymously enter patient data to the international Zika virus registry, which collects data on women exposed to the mosquito-borne virus during pregnancy.

Emily Heil, PharmD, BCPS-AQ ID, assistant professor at the University of Maryland School of Pharmacy, and Contagion® Editorial Advisory Board Member, discusses some points to be mindful of when considering IV to PO conversions.

Belinda Ostrowsky, MD, MPH, Health Systems Director of Epidemiology, Antimicrobial Stewardship & Infection Prevention, Montefiore Medical Center, and Associate Professor of Clinical Medicine, Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, discusses limitations to C. difficile testing that could impact stewardship practices in healthcare facilities.

Robin Jump, MD, PhD, discussed the challenges associated with isolation precautions in long-term care settings, specifically nursing homes during her presentation at the SHEA Spring 2017 Conference on March 30, 2017.

At the SHEA Spring 2017 Conference on March 30, 2017, David P. Calfee, MD, MS, discussed the role that the environment plays in transmission of healthcare-associated infections, and why cleaning and disinfection measures need to be improved to reduce these infections.

Emily Heil, PharmD, BCPS-AQ ID, assistant professor at the University of Maryland School of Pharmacy, and Contagion® Editorial Advisory Board Member, explains why it is important that antibiotic stewards understand pharmacokinetics and pharmacodynamics.

Rita Olans, DNP, CPNP-PC, APRN-BC, assistant professor at MGH Institute of Health Professions, explains the importance of involving nurses in antimicrobial and antibiotic stewardship programs in hospitals.

Patient advocate Liz Kruvand brought a fresh perspective to the SHEA Spring 2017 Conference when she discussed her own trials and tribulations with infection prevention in the pediatric hospital setting.

Rebekah Moehring, MD, MPH, shared strategies for building internal capacity to meet infection prevention goals in resource-limited settings at the SHEA Spring 2017 Conference on March 29, 2017.

Lauri A. Hicks, DO, Director, Office of Antibiotic Stewardship, Centers for Disease Control and Prevention, explains an area of debate in the general medical field regarding antibiotics.

At the Society for Healthcare Epidemiology of America (SHEA) Spring 2017 Conference, Nimalie Stone, MD, MS, Team Lead, LTC, Division of Healthcare Quality Promotion at the Centers for Disease Control and Prevention (CDC), discussed infection prevention and control programs in nursing homes across the United States.

On March 30, 2017, at the SHEA Spring 2017 Conference, Thomas Sandora, MD, MPH, shared some tips regarding ways to manage movement outside of the room for patients who are on contact precautions.

Belinda Ostrowsky, MD, MPH, Health Systems Director of Epidemiology, Antimicrobial Stewardship & Infection Prevention, Montefiore Medical Center, and Associate Professor of Clinical Medicine, Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, explains how to be more sensible when it comes to testing for Clostridium difficile.

Matt Linam, MD, MS, Assistant Professor, Pediatric Infectious Diseases, University of Arkansas for Medical Sciences, explains the best ways to reduce the number of respiratory viral healthcare-associated infections in children.

On March 30, 2017, at the SHEA Spring 2017 Conference, Matt Linam, MD, MS, discussed strategies to prevent healthcare workers from spreading healthcare-associated infections (HAIs).

On March 30, 2017, plenary speaker Matthew Kreuter, PhD, MPH, provided SHEA Spring 2017 Conference attendees with insight on how behavior change strategies play a part in infection prevention in hospital settings.

Snigdha Vallabhaneni, MD, MPH, Medical Epidemiologist, Mycotic Diseases Branch at the Centers for Disease Control and Prevention, discusses the threat that is Candida auris.

Nimalie Stone, MD, MS, Team Lead, LTC, Division of Healthcare Quality Promotion at the Centers for Disease Control and Prevention, explores the differences in infrastructure for clinical care and infection prevention in post–acute care and long-term care settings as compared to acute care hospitals.